Recently, Armstrong et al. reported a systematic review and CEA of thrombopoietin receptor agonists avatrombopag ((Doptelet®; Dova Pharmaceuticals, Durham, NC, USA) and LUSU for thrombocytopenia in people with CLD needing an elective procedure.27 This evidence concerns the gene MPL and congenital secretory chloride diarrhea 1.